Alberts on Neurology

 
 
  • Minor Stroke: Combo Therapy vs Aspirin Alone   Dr. Mark Alberts comments on the results of the CHANCE trial, which compared combination therapy with aspirin alone for TIA or minor stroke.
  • Rapid BP Lowering Following Intracerebral Hemorrhage   Dr. Mark Alberts discusses a study assessing the timely lowering of elevated blood pressure to improve outcomes in patients with intracerebral hemorrhage.
  • 'Time Is Brain'   A new study looks at how time to treatment with IV tPA affects outcomes in acute ischemic stroke.
  • New Ischemic Stroke Guidelines: The Nuts and Bolts   Dr. Mark Alberts dissects the new AHA/ASA guidelines for the early management of acute ischemic stroke.
  • Four Helpful Stroke Studies   A possible cause of transient global amnesia, a novel approach to CT scans, and other important data in stroke.
  • Aspirin, Clopidogrel, and Lacunar Stroke   Dr. Mark Alberts discusses the SPS3 trial which looked at aspirin monotherapy vs aspirin plus clopidogrel in patients with recent lacunar stroke.
  • Informed Consent for Stroke Care (For Now, Anyway)   Dr. Mark Alberts discusses the FDA's recent decision to deny expanding the IV TPA window to 4.5 hours. What does this mean for stroke care?
  • An Important Update on Thrombolysis in Acute Stroke   Dr. Mark Alberts provides an update on the International Stroke Trial-3 looking at the safety and efficacy of intravenous tPA.
  • Another Antiplatelet Option?   Dr. Mark Alberts discusses a recent trial on novel antiplatelet agent vorapaxar in the secondary prevention of atherothrombotic events.
  • Closure on CLOSURE for Patent Foramen Ovale?   Is PFO closure more beneficial than medical therapy in patients with cryptogenic stroke? Dr. Mark Alberts describes the results of the CLOSURE study.
  • Does Chiropractic Care Increase Stroke Risk?   Dr. Mark Alberts discusses the risk for arterial dissection and stroke associated with chiropractic spinal and neck manipulation.
  • A New Stroke Certification?   Dr. Mark Alberts discusses new data on stroke outcomes along with a new process for stroke center certification.
  • Another Win for Aspirin in Stroke?   A study presented at this year's International Stroke Conference Annual Meeting compares monotherapy and polytherapy in patients with small subcortical strokes.
  • Warfarin vs Aspirin for Stroke Prevention   A study presented at this year's International Stroke Conference Annual Meeting compares warfarin with aspirin for stroke prevention in patients with heart failure and reduced ejection fraction.
  • Rivaroxaban Approved! Now How Do We Use It?   Dr. Mark Alberts discusses the clinical implications of rivaroxaban's recent FDA approval for the prevention of stroke in patients with atrial fibrillation.
  • A New Option in Stroke Prophylaxis?   Dr. Mark Alberts discusses the results of the ROCKET AF trial comparing the oral anticoagulant rivaroxaban with warfarin for stroke prophylaxis in patients with atrial fibrillation.
  • Stenting vs Medical Therapy in Intracranial Stenosis   Dr. Mark Alberts discusses recently reported results of the SAMMPRIS trial comparing stenting vs aggressive medical therapy for intracranial arterial stenosis.
  • Stroke in Young Adults: Are Statins the Answer?   Dr. Mark Alberts discusses a recent study published in Neurology assessing the efficacy of statins in preventing recurrence in young adults who have experienced stroke of unknown cause.
  • Embolectomy for Ischemic Stroke: A Look at Outcomes   Dr. Mark Alberts discusses a new study published in Stroke evaluating endovascular embolectomy therapy outcomes for acute ischemic stroke.
  • Is 90 mg TPA Enough in Overweight Patients?   Dr. Mark Alberts discusses a new study in Stroke assessing whether the maximum TPA dose of 90 mg is enough for patients weighing more than 100 kg.